|
 |
|
 |
|
 |
| |
|
Surat, India, April 21, 2010 - Two years clinical outcome of Sahajanand Medical Technologies Supralimus-Sirolimus Eluting stent with Bioabsorbable Polymer in patients with Acute Coronary Syndrome is publish in Journal of the American College of Cardiology (JACC) as a part of an E-Series registry - A multicenter, open-labeled, non-randomized study with non-selected pts treated with SS.
Read More... |
|
|
|
|
|
|
|
|
 |
Supralimus-Core™ Sirolimus Eluting Coronary Stent System is based on the
three powerful... Learn More... |
|
|
|
 |
The Supralimus®
is based on the three powerful tools. The CE approved The
Millennium Matrix® Stent... Learn More... |
|
|
|
 |
The Coronnium® (CE approved)
Cobalt Chromium Coronary Stent System contains... Learn More... |
|
|
|
 |
The Infinnium®
(CE approved)
Paclitaxel
Eluting Coronary Stent System contains Biodegradable... Learn More... |
|
|
|
 |
The Millennium Matrix®
(CE approved)
Coronary Stent System contains excellent technical features
like... Learn More... |
|
|
|
ShareThis |
